REFERENCES

1. Clapp JF, Seaward BL, Sleamaker RH, Hiser J. Maternal physio­logic adaptations to early human pregnancy. Am J Obstet Gynecol 1988;159:1456-60.

2. Johnson MR, von Klemperer K.

3. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, patho­physiology and pharmacology. Pharmacol Rev 1991;43:109-42.

4. Wang Y, Zhao S. Placental blood circulation. In: Vascular Biology of the Placenta, pp. 3-12. San Rafael, CA: Morgan and Claypool Life Sciences; 2010.

5. Steer PJ, Little MP, Kold-Jensen T, Chapple J, Elliott P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 2004;329:1312.

6. Robson SC, Dunlop W, Boys RJ, Hunter S. Cardiac output during labour. Br Med J (Clin Res Ed) 1987;295:1169-72.

7. Stout K. Pregnancy in women with congenital heart disease: the importance of evaluation and counselling. Heart 2005;91:713-14.

8. Somerville J. Near misses and disasters in the treatment of grown­up congenital heart patients. J Roy Soc Med 1997;90:124-27.

9. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006­2008. The Eighth Report ofthe Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 Suppl 1:1-203.

10. MBRRACE-UK. Saving Lives, Improving Mother’s Care. 2014. Available at: https://www.npeu.ox.ac.uk/downloads/ files∕mbrrace-uk∕reports∕Saving%20Lives%20Improving%20 Mothers%20Care%20report%202014%20Full.pdf.

11. Scott-Pillai R, Spence D, Cardwell C, Hunter A, Holmes V The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011.

12. Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol 2011;58:337-50.

13. Elkayam U. Clinical characteristics of peripartum cardiomyop­athy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011;58:659-70.

14. Ersboll AS, Hedegaard M, Sondergaard L, Ersboll M, Johansen M. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restric­tion. BJOG 2014;121:618-26.

15. Cauldwell M, Von Klemperer K, Uebing A, et al. A cohort study of women with a Fontan circulation undergoing preconception counselling. Heart 2016;102:534-40.

16. Cauldwell M, Steer PJ, Johnson M, Gatzoulis M. Counselling women with congenital cardiac disease. BMJ 2016;352:i910.

17. Montgomery (Appellant) v Lanarkshire Health Board (Respondent) (Scotland) [2015] (UKSC 11). Available at: https:// www.supremecourt.uk/decided-cases/docs/UKSC_2013_0136_ Judgment pdf.

18. Bolton H. The Montgomery ruling extends patient autonomy. BJOG 2015;122:1273.

19. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21.

20. Regitz-Zagrosek V, Lundqvist CB, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during preg­nancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-97.

21. Regitz-Zagrosek V, Gohlke-B arwolf C, Iung B, Pieper PG. Management of cardiovascular diseases during pregnancy. Curr Probl Cardiol 2014;39:85-151.

22. Burn J, Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998;351:311-16.

23. Roos-Hesselink JW, van Hagen IM. Ischemic heart disease. In: Steer PJ, Gatzoulis MA (eds), Heart Disease and Pregnancy, 2nd edn, pp.

24. Grewal J, Siu SC, Ross HJ, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2009;55:45-52.

25. Nelson-Piercy C, Head C. Peripartum and other cardiomyop­athies in pregnancy. In: Steer PJ, Gatzoulis MA (eds), Heart Disease and Pregnancy, 2nd edn, pp. 160-73. Cambridge: Cambridge University Press; 2016.

26. Elkayam U, Goland S. Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation 2010;121:1463-64.

27. Desplantie O, Tremblay-Gravel M, Avram R, Marquis-Gravel G, Ducharme A, Jolicoeur EM. The medical treatment of new-onset peripartum cardiomyopathy: a systematic review of prospective studies. Can J Cardiol 2015;31:1421-26.

28. Bouabdallaoui N, Mouquet F, Lebreton G, Demondion P, Le Jemtel TH, Ennezat PV. Current knowledge and recent develop­ment on management of peripartum cardiomyopathy. Eur Heart J Acute Cardiovasc Care 2017;6:359-66.

29. Thorne SA. Management ofmitral and aortic stenosis in pregnancy. In: Steer PJ, Gatzoulis MA (eds), Heart Disease and Pregnancy, 2nd edn, pp. 125-30. Cambridge: Cambridge University Press; 2016.

30. Yates MT, Soppa G, Smelt J, et al. Perioperative management and outcomes of aortic surgery during pregnancy. J Thorac Cardiovasc Surg 2015;149:607-10.

31. Swan L. Management ofaortopathies, including Marfan syndrome, in pregnancy. In: Steer PJ, Gatzoulis MA (eds), Heart Disease and Pregnancy, 2nd edn, pp. 115-24. Cambridge: Cambridge University Press; 2016.

32. Vriz O, Aboyans V, D’Andrea A, et al. Normal values of aortic root dimensions in healthy adults. Am J Cardiol 2014;114:921-27.

33. Curry RA, Gelson E, Swan L, et al. Marfan syndrome and preg­nancy: maternal and neonatal outcomes. BJOG 2014;121:610-17.

34. Mayet J, Steer P, Somerville J. Marfan syndrome, aortic dilatation, and pregnancy. Obstet Gynecol 1998;92 4 II Suppl:713.

35. Jensen AS, Sondergaard L, Uebing A. Management ofright heart le­sions in pregnancy.

36. Gelson E, Gatzoulis M, Steer PJ, Lupton M, Johnson M. Tetralogy of Fallot: maternal and neonatal outcomes. BJOG 2008;115:398-402.

37. Curry RA, Fletcher C, Gelson E, et al. Pulmonary hypertension and pregnancy - a review of 12 pregnancies in nine women. BJOG 2012;119:752-61.

38. Kiely DG, Elliot CA, Sabroe I, Condliffe R. Pulmonary hyperten­sion: diagnosis and management. BMJ 2013;346:f2028.

39. Enriquez AD, Economy KE, Tedrow UB. Contemporary man­agement of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol 2014;7:961-67.

40. Basude S, Hein C, Curtis SL, Clark A, Trinder J. Low-molecular- weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retro­spective observational study. BJOG 2012;119:1008-13.

41. van Hagen IM, Roos-Hesselink JW, Ruys TP, et al. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation 2015;132:132-42.

42. Suri V, Keepanasseril A, Aggarwal N, et al. Mechanical valve pros­thesis and anticoagulation regimens in pregnancy: a tertiary centre experience. Eur J Obstet Gynecol Reprod Biol 2011;159:320-23.

43. National Institute for Health and Care Excellence (NICE). Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures. Clinical guideline [CG64], updated 2016. London: NICE; 2008. Available at: https://www. nice.org.uk/guidance/cg64/chapter/Recommendations.

44. Stokes T, Richey R, Wray D. Prophylaxis against infective endo­carditis: summary of NICE guidance. Heart 2008;94:930-31.

45. Ruys TP, Roos-Hesselink JW, Pijuan-Domenech A, et al. Is a planned caesarean section in women with cardiac disease benefi­cial? Heart 2015;101:530-36.

46. Steer PJ, Modi N. Elective caesarean sections - risks to the infant. Lancet 2009;374:675-76.

47. Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br J Anaesth 2008;101:822-26.

48. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth 2007;98:116-19.

49. Tsui BC, Stewart B, Fitzmaurice A, Williams R. Cardiac arrest and myocardial infarction induced by postpartum intravenous ergonovine administration. Anesthesiology 2001;94:363-64.

50. World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 5th edn. 2015. Available at: http://wwwwhoint/ reproductivehealth/publications/family_planning/Ex-Summ- MEC-5/en/ (accessed 15 November 2015).

51. de Bastos M, Stegeman BH, Rosendaal FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014;3:CD010813.